SEC Form 4 · accession 0000899243-16-020663
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Ling Lee
Officer — See Remarks
Period of report
May 18, 2016
Accepted (ET)
May 20, 2016 · 7:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 18, 2016 | A | 10,080 | A | — | — | Common Stock | 10,080 | 10,080 | D |
| Employee Stock Option (Right to Buy)F3 | $8.98 | May 18, 2016 | A | 13,400 | A | — | May 18, 2026 | Common Stock | 13,400 | 13,400 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit.
- F212/48th of the total number of shares underlying the Restricted Stock Units granted will vest on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to the recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date.
- F312/48th of the total number of shares subject to the Option will vest on May 16, 2017 and 1/48th of the total shares subject to the Option will vest and become exercisable each month thereafter over the succeeding 36 months, such that the Option will be fully vested on May 16, 2020, subject to the recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan.
Remarks
VICE PRESIDENT, CONTROLLER, AND PRINCIPAL ACCOUNTING OFFICER